Aridis Pharmaceuticals Eulerpool News

Aridis Pharmaceuticals Eulerpool News

Aridis Pharmaceuticals Stock News

Aridis Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest Aridis Pharmaceuticals news here.

• June 24 ·

  Yahoo
  Aridis Provides Corporate Update
• February 12 ·

  GuruFocus
  Aridis Pharmaceuticals Inc Investor Update Call Transcript
• December 15 ·

  Yahoo
  Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
• November 6 ·

  TipRanks
  Promising Developments and Value Proposition: A Buy Rating Analysis of Aridis Pharmaceuticals
• November 3 ·

  Yahoo
  Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
• November 3 ·

  Seeking Alpha
  Aridis Pharmaceuticals GAAP EPS of $0.00 beats by $0.10, revenue of $0.42M misses by $1.08M
• October 21 ·

  Fintel
  HC Wainwright & Co. Maintains Aridis Pharmaceuticals (ARDS) Buy Recommendation
• October 20 ·

  TipRanks
  FDA’s Qualified Infectious Disease Product Designation Bolsters Aridis Pharmaceuticals’ Investment Appeal: An Analyst’s Buy Recommendation
• October 20 ·

  Thefly.com
  Aridis Pharmaceuticals price target lowered to $2 from $10 at H.C. Wainwright
• September 22 ·

  Yahoo
  Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV